The need for three doses for similar protection has large implications for China
the world, hard lockdowns to curb transmission of SARS-CoV-2 seem a thing of the past. Not in China. On April 19th, Shanghai entered its third week of a, having registered 19,442 new transmissions the day before . The disruptions clearly have a huge human and economic cost, but the government appears to have no clear plan B. The main problem is that the elderly in China are insufficiently vaccinated.
A study by the University of Hong Kong has for the first time compared the effectiveness of China’s Sinovac vaccine with the mRNA vaccine developed by BioNTech against the Omicron variant of the virus . Both vaccines work: at three doses they were estimated to offer over 90% protection against severe disease and death across all age groups. But without a booster, significant differences between the two vaccines emerged. With two doses, the BioNTech shot was 75-96% protective across age groups.
The estimates are subject to the usual caveats. The authors cautioned that the higher effectiveness of the third dose may in part be due to how recently it was administered. Mild infections may have also gone undetected, and links between vaccination and risky behaviour and underlying conditions also play a part. Though not as rigorous as a head-to-head clinical trial, the study provides the best evidence so far of how these vaccines do against Omicron.
The Chinese shot may also be less effective at limiting infections. For those aged under 60 in Hong Kong, the German-developed vaccine significantly limited even mild cases of Omicron after just one jab. In contrast, for mild infections, Sinovac’s shot had no detectable impact after one or two doses, and offered only about half the protection of the mRNA vaccine after three .
The implications for China are grim. Just slightly more than 50% of the population has been boosted and, by March 17th, less than half of those aged over 70 had received a third dose, according to the country’s National Health Commission. Many old people are not vaccinated at all. China initially approved shots only for healthy people under 60, leading to concerns that. With vaccines that do a poorer job of limiting infection, transmission will be high.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Solomon Islands-China pact is worst policy failure in Pacific since 1945, Labor saysPenny Wong accuses Coalition of mishandling situation, raising concerns of a potential Chinese military presence in South Pacific
Read more »
Le Pen calls for close ties with Putin to avoid 'great danger' of Russia-China allianceMARINE LE PEN has called for France to 'engage' with Russia after the war in Ukraine in order to prevent an alliance between Russia and China.
Read more »
Cancer vaccine using same tech as Covid jabs could be a 'game-changer'Zachary Hartman, an assistant professor in immunology at Duke University, North Carolina, said: 'If we can roll this out in the clinic for cancer, we think it could be a game-changer.'
Read more »